Viatris management check
VTRS · Health Care · Pharmaceuticals · CEO Scott A. Smith
Filings as of
Closest peers in Pharmaceuticals
- 35LLYLilly (Eli)84
- 181JNJJohnson & Johnson70
- 195ZTSZoetis68
- 261MRKMerck & Co.64
- 277PFEPfizer63
- 335BMYBristol Myers Squibb59
- 369VTRSViatris57
The seven checks
- FlagTrailed its chosen peers
Have owners done well?
What $100 became since fiscal 2021
016thDetail
$100 invested at the start of fiscal 2021 grew to $81, against $186 for the peer group the company picked itself.
- GoodPay rose and fell with returns
Does pay follow performance?
Pay actually paid $100 value, each on its own scale
8147thDetail
Over 5 years, the CEO's pay actually paid (equity valued at the share price) had a correlation of 0.63 with shareholder return. 1 means pay moved in step; below 0, the opposite way.
- n/aNot enough data
What does the CEO cost owners?
——No pay or net income figure for the latest year.
- n/aNo recent CEO filing
Do they own the stock?
——Light activity: no buys, $810k sold in six months. 1 of 1 sales ran on pre-arranged 10b5-1 plans.
- WatchStock pay 1.2% of revenue
Are owners being diluted?
Stock pay 1.2% of revenue
9281stDetail
Stock-based pay was 1.2% of revenue in the latest year.
- Watch2 CEOs in the pay table
Is leadership stable?
9 filings under 8-K 5.02 in 3 years
CEOs: Michael Goettler, Scott A. Smith
4018thDetail
CEOs in the pay table: Michael Goettler, Scott A. Smith. 9 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- WatchAn annual report was amended
Are the books clean?
Since 2021
- 0Restated
- 0Auditor changes
- 0Late filings
- 410-K amended
7015thDetail
No restatements, auditor changes or late filings since 2021. 4 amended annual reports.
Reading the scores
Each check scored 0–100 from its own figure. The tick is the Health Care median; the ordinal is the share of ranked S&P 500 companies it matches or beats.
Hover a chart for its figures. Detail has the full reading.
Pay versus performance
From the proxy statement filed April 2, 2026.
Pay tied most to Free Cash Flow
Other key measuresAdjusted EBITDARelative TSR
Show the figures
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2025 | Scott A. Smith | $15.3m | $24.7m | $5.2m | $81 | $186 | — |
| 2024 | Scott A. Smith | $14.8m | $17.8m | $5.5m | $77 | $145 | — |
| 2023 | Michael Goettler, Scott A. Smith | $15.9m | $17.8m | $14.3m | $65 | $135 | — |
| 2022 | Michael Goettler | $14.8m | $14.3m | $14.9m | $63 | $135 | — |
| 2021 | Michael Goettler | $14.8m | $13.6m | $10.5m | $74 | $125 | — |
Insiders and the CEO's stakeQuiet
Light activity: no buys, $810k sold in six months. 1 of 1 sales ran on pre-arranged 10b5-1 plans.
Open-market trades by officers and directors since May 21, 2026.
- SoldPaul CampbellSee Remarks · 10b5-1 plan$810kJun 25, 2026
Leadership and governance on file
All 18 filings
- May 4, 2026Leadership change8-K 5.02
- Feb 3, 2026Leadership change8-K 5.02
- Dec 5, 2025Leadership change8-K/A 5.02
- Aug 5, 2025Leadership change8-K 5.02
- May 5, 2025Leadership change8-K 5.02
- Apr 30, 2025Annual report amended10-K/A
- Dec 6, 2024Leadership change8-K 5.02
- Jun 3, 2024Leadership change8-K 5.02
- Apr 26, 2024Annual report amended10-K/A
- Dec 15, 2023Leadership change8-K/A 5.02
- Dec 15, 2023Leadership change8-K 5.02
- Oct 20, 2023Leadership change8-K 5.02
- May 22, 2023Leadership change8-K 5.02
- Apr 28, 2023Annual report amended10-K/A
- Feb 27, 2023Leadership change8-K/A 5.02
- Feb 27, 2023Leadership change8-K 5.02
- Dec 29, 2022Leadership change8-K 5.02
- Apr 29, 2022Annual report amended10-K/A
Latest shareholder vote results: May 15, 2026, including the say-on-pay vote.
Where the money went
2021–2025: $1.0bn returned to owners in buybacks and dividends, and $732.1m of pay in stock.
Show the figures
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $17.8bn | $16.2bn | $15.4bn | $14.7bn | $14.3bn |
| Net income | — | — | — | — | — |
| Stock-based pay | $111.2m | $116.4m | $180.7m | $146.1m | $177.7m |
| Buybacks | $0 | $0 | $250.0m | $250.0m | $500.5m |
| Dividends | — | — | — | — | — |
| Diluted shares | 1209m | 1217m | 1207m | — | — |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.